Roux-en-Y gastric bypass (RYGB) with simultaneous cholecystectomy had a significantly higher complication rate and took more than 1 hour longer than RYGB without cholecystectomy.
Researchers examined the nonvertebral fracture risk in adults with obesity who underwent Roux-en-Y gastric bypass vs adjustable gastric banding.
Severely obese adolescents who underwent gastric bypass surgery experienced significant weight loss that was maintained over long-term follow-up.
Gastric bypass, but not gastric banding, is associated with reduced risk of psoriasis, progression to severe psoriasis, and psoriatic arthritis.
Patients who undergo Roux-en-Y gastric bypass are less likely to die from obesity or other diseases than those who did not undergo the procedure 10 years later.
After Roux-en-Y gastric bypass surgery, variations in rates of diabetes remission are primarily related to differences in the definition of remission and study duration.
A patient came to the clinic to discuss her dizzy spells 4 years after her Roux-en-Y gastric bypass surgery.
The addition of Roux-en-Y gastric bypass to lifestyle-medical management is associated with improved achievement of treatment goals in type 2 diabetes.
Gastric bypass surgery is associated with reduced symptoms and neurohormonal responses to hypoglycemia, according to a study published in Diabetes.
An array of changes in protein abundance in skeletal muscle were observed before and after RYGB surgery.
As DiaRem score increases, the proportion of patients experiencing remission decreases.
The temporary 1-year intestinal bypass device with liraglutide boosts weight loss and improves diabetes control.
Compared with a rigorous lifestyle and medical intervention, gastric bypass surgery led to greater remission of type 2 diabetes.
Gastric bypass is linked to reduced mortality in patients aged older than 35.
Patients who underwent gastric bypass reported improved well-being, but symptoms and hospitalizations were high after the procedure.
A decrease was seen after gastric bypass for patients with type 2 diabetes, but not with normal glucose tolerance.
Surgery associated with significantly lower plasma lipids, CV risk, medication use vs. drug therapy.
Researchers found blood alcohol levels were doubled in women who had gastric bypass.
A 3.5-fold AMPK activity increase and 50% drop in oxidative stress 3 months after surgery.
Combining Roux-en-Y gastric bypass with a drug that targets the serotonin C receptor, like lorcaserin, may increase weight loss after the procedure.
Researchers saw a 50% decrease in oxidative stress.
Weight loss, improvements in metabolic parameters better with duodenal switch in patients with BMIs exceeding 50.
RYGB predicts insulin therapy cessation early after surgery, independent of weight.
Obese patients who underwent bariatric surgery had lower mortality rates compared with those who did not undergo the procedure.
Laparoscopic gastric bypass surgery has a complication and mortality rate comparable to some of the safest, most commonly performed procedures.
Gastric bypass helps patients lose more weight than gastric banding but also has a higher risk for complications and hospitalizations.
Obese adults may benefit more from gastric bypass than gastric band procedures in terms of weight loss and diabetes management.
Vagal nerve block therapy may be effective for weight loss in morbid obesity, and trends in bariatric surgery procedures have changed from 2006 to 2013.
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia